Log in

NYSEAMERICAN:PTN - Palatin Technologies Stock Price, Forecast & News

$0.71
+0.01 (+1.43 %)
(As of 01/24/2020 03:55 AM ET)
Today's Range
$0.69
Now: $0.71
$0.72
50-Day Range
$0.87
MA: $0.93
$1.06
52-Week Range
$0.65
Now: $0.71
$1.78
Volume801,000 shs
Average Volume1.35 million shs
Market Capitalization$162.67 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Palatin Technologies, Inc, a biopharmaceutical company, develops targeted, receptor-specific therapeutics for the treatment of various diseases in the United States. The company's principal product is Vyleesi, an on demand subcutaneous injectable product that has completed Phase III clinical studies for the treatment of premenopausal women with acquired, generalized hypoactive sexual desire disorder. Read More…

Industry, Sector and Symbol

Stock Exchange NYSEAMERICAN
Industry Diagnostics & Research
Sub-IndustryN/A
SectorMedical
Current SymbolNYSEAMERICAN:PTN
CUSIPN/A
Phone+1-609-4952200

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees19
Market Cap$162.67 million
Next Earnings Date2/11/2020 (Estimated)
OptionableNot Optionable

Receive PTN News and Ratings via Email

Sign-up to receive the latest news and ratings for PTN and its competitors with MarketBeat's FREE daily newsletter.


Palatin Technologies (NYSEAMERICAN:PTN) Frequently Asked Questions

What is Palatin Technologies' stock symbol?

Palatin Technologies trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "PTN."

How were Palatin Technologies' earnings last quarter?

Palatin Technologies, Inc. (NYSEAMERICAN:PTN) posted its quarterly earnings results on Wednesday, November, 13th. The biopharmaceutical company reported ($0.02) EPS for the quarter, hitting the Thomson Reuters' consensus estimate of ($0.02). The biopharmaceutical company earned $0.10 million during the quarter, compared to analysts' expectations of $3.28 million. During the same period in the prior year, the business earned ($0.03) EPS. View Palatin Technologies' Earnings History.

When is Palatin Technologies' next earnings date?

Palatin Technologies is scheduled to release their next quarterly earnings announcement on Tuesday, February 11th 2020. View Earnings Estimates for Palatin Technologies.

What price target have analysts set for PTN?

3 Wall Street analysts have issued 1 year target prices for Palatin Technologies' shares. Their forecasts range from $2.00 to $6.00. On average, they expect Palatin Technologies' share price to reach $3.67 in the next year. This suggests a possible upside of 416.4% from the stock's current price. View Analyst Price Targets for Palatin Technologies.

What is the consensus analysts' recommendation for Palatin Technologies?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Palatin Technologies in the last year. There are currently 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Palatin Technologies.

Has Palatin Technologies been receiving favorable news coverage?

News articles about PTN stock have been trending negative on Friday, according to InfoTrie Sentiment Analysis. The research group identifies negative and positive news coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Palatin Technologies earned a daily sentiment score of -2.6 on InfoTrie's scale. They also gave media coverage about the biopharmaceutical company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the stock's share price in the near future. View News Stories for Palatin Technologies.

Who are some of Palatin Technologies' key competitors?

What other stocks do shareholders of Palatin Technologies own?

Who are Palatin Technologies' key executives?

Palatin Technologies' management team includes the folowing people:
  • Dr. John K. A. Prendergast, Co-Founder & Non-Exec. Chairman (Age 65)
  • Dr. Carl Spana, Co-Founder, Pres, CEO & Director (Age 57)
  • Mr. Stephen T. Wills CPA, CPA, MST, CFO, COO, Exec. VP, Treasurer & Sec. (Age 62)
  • Burns McClellan, VP of Investor Relations

How do I buy shares of Palatin Technologies?

Shares of PTN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Palatin Technologies' stock price today?

One share of PTN stock can currently be purchased for approximately $0.71.

How big of a company is Palatin Technologies?

Palatin Technologies has a market capitalization of $162.67 million. Palatin Technologies employs 19 workers across the globe.View Additional Information About Palatin Technologies.

What is Palatin Technologies' official website?

The official website for Palatin Technologies is http://www.palatin.com/.

How can I contact Palatin Technologies?

Palatin Technologies' mailing address is 4B Cedarbrook Dr, CRANBURY, NJ 08512-3641, United States. The biopharmaceutical company can be reached via phone at +1-609-4952200.


MarketBeat Community Rating for Palatin Technologies (NYSEAMERICAN PTN)

Community Ranking:  3.0 out of 5 (star star star)
Outperform Votes:  399 (Vote Outperform)
Underperform Votes:  276 (Vote Underperform)
Total Votes:  675
MarketBeat's community ratings are surveys of what our community members think about Palatin Technologies and other stocks. Vote "Outperform" if you believe PTN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PTN will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/24/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel